Dhaval K Shah

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Venues

Journal of pharmacokinetics and pharmacodynamics

ACS nano

Pharmaceutics

British journal of clinical pharmacology

University at Buffalo - The State University of New York (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University at Buffalo - The State University of New York

United States

PHD :: Pharmaceutical Sciences

National Institute of Pharmaceutical Education and Research

India

MSC :: Pharmaceutics

Publications

Ingrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, Swetha Reddy Allamreddy, Shrusti Tiwari, Dhaval K Shah, Rita Basu, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS nano 18 (18) (2024)
Hsuan Ping Chang, Yuen Kiu Cheung, Shufang Liu, Dhaval K Shah
Development of a generalized pharmacokinetic model to characterize clinical pharmacokinetics of monomethyl auristatin E-based antibody-drug conjugates. British journal of clinical pharmacology 90 (7) (2024)
Hsuan Ping Chang, Yuen Kiu Cheung, Shufang Liu, Dhaval K Shah
Development of a generalized pharmacokinetic model to characterize clinical pharmacokinetics of monomethyl auristatin E-based antibody-drug conjugates. British journal of clinical pharmacology (2024)
Mokshada Kumar, Sravani Lanke, Alka Yadav, Mfonabasi Ette, Donald E Mager, Dhaval K Shah
Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling. Antibodies (Basel, Switzerland) 13 (3) (2024)
Ingrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, Swetha Reddy Allamreddy, Shrusti Tiwari, Dhaval K Shah, Rita Basu, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS nano 18 (18) (2024)
Ingrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, Swetha Reddy Allamreddy, Shrusti Tiwari, Dhaval K Shah, Rita Basu, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS nano 18 (18) (2024)
Mokshada Kumar, Sravani Lanke, Alka Yadav, Mfonabasi Ette, Donald E Mager, Dhaval K Shah
Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling. Antibodies (Basel, Switzerland) 13 (3) (2024)
Ingrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, Swetha Reddy Allamreddy, Shrusti Tiwari, Dhaval K Shah, Rita Basu, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS nano 18 (18) (2024)
Hsuan Ping Chang, Yuen Kiu Cheung, Shufang Liu, Dhaval K Shah
Development of a generalized pharmacokinetic model to characterize clinical pharmacokinetics of monomethyl auristatin E-based antibody-drug conjugates. British journal of clinical pharmacology 90 (7) (2024)
Ingrid Marie Heyns, Meenakshi Arora, Raghu Ganugula, Swetha Reddy Allamreddy, Shrusti Tiwari, Dhaval K Shah, Rita Basu, Naga Venkata Ravi Kumar Majeti
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein. ACS nano (2024)
Hsuan Ping Chang, Huyen Khanh Le, Dhaval K Shah
Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes. Pharmaceutics 15 (4) (2023)
Hsuan Ping Chang, Huyen Khanh Le, Dhaval K Shah
Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes. Pharmaceutics 15 (4) (2023)
Hsuan Ping Chang, Huyen Khanh Le, Dhaval K Shah
Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes. Pharmaceutics 15 (4) (2023)
Hsuan Ping Chang, Huyen Khanh Le, Dhaval K Shah
Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes. Pharmaceutics 15 (4) (2023)
Shufang Liu, Ashwni Verma, Hubert Kettenberger, Wolfgang F Richter, Dhaval K Shah
Effect of variable domain charge on in vitro and in vivo disposition of monoclonal antibodies. mAbs 13 (1) (2022)
Hsuan-Ping Chang, Zhe Li, Dhaval K Shah
Development of a Physiologically-Based Pharmacokinetic Model for Whole-Body Disposition of MMAE Containing Antibody-Drug Conjugate in Mice. Pharmaceutical research 39 (1) (2022)
Hsueh-Yuan Chang, Shengjia Wu, Ekram Ahmed Chowdhury, Dhaval K Shah
Towards a translational physiologically-based pharmacokinetic (PBPK) model for receptor-mediated transcytosis of anti-transferrin receptor monoclonal antibodies in the central nervous system. Journal of pharmacokinetics and pharmacodynamics 49 (3) (2022)
Lyndsey F Meyer, Pooja M Rajadhyaksha, Dhaval K Shah
Physiologically-based pharmacokinetic model for 2,4-dinitrophenol. Journal of pharmacokinetics and pharmacodynamics 49 (3) (2022)
Hsuan Ping Chang, Valentina Shakhnovich, Adam Frymoyer, Ryan Sol Funk, Mara L Becker, K T Park, Dhaval K Shah
A population physiologically-based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab. British journal of clinical pharmacology (2021)
Hsueh-Yuan Chang, Shengjia Wu, Yingyi Li, Wanying Zhang, Matthew Burrell, Carl I Webster, Dhaval K Shah
Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis. mAbs 13 (1) (2021)
Hsuan Ping Chang, Yuen Kiu Cheung, Dhaval K Shah
Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE). Journal of clinical medicine 10 (6) (2021)
Zhe Li, Yingyi Li, Hsuan Ping Chang, Xiaoying Yu, Dhaval K Shah
Two-pore physiologically based pharmacokinetic model validation using whole-body biodistribution of trastuzumab and different-size fragments in mice. Journal of pharmacokinetics and pharmacodynamics 48 (5) (2021)
Sharad Sharma, Zhe Li, David Bussing, Dhaval K Shah
Evaluation of Quantitative Relationship Between Target Expression and Antibody-Drug Conjugate Exposure Inside Cancer Cells. Drug metabolism and disposition: the biological fate of chemicals 48 (5) (2020)
David Bussing, Dhaval K Shah
Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbits. Journal of pharmacokinetics and pharmacodynamics 47 (6) (2020)
Zhe Li, Dhaval K Shah
Two-pore physiologically based pharmacokinetic model with de novo derived parameters for predicting plasma PK of different size protein therapeutics. Journal of pharmacokinetics and pharmacodynamics 46 (3) (2019)
Aman P Singh, Leiming Guo, Ashwni Verma, Gloria Gao-Li Wong, Dhaval K Shah
A Cell-Level Systems PK-PD Model to Characterize In Vivo Efficacy of ADCs. Pharmaceutics 11 (2) (2019)
Antari Khot, Satoko Matsueda, Veena A Thomas, Richard C Koya, Dhaval K Shah
Measurement and Quantitative Characterization of Whole-Body Pharmacokinetics of Exogenously Administered T Cells in Mice. The Journal of pharmacology and experimental therapeutics 368 (3) (2019)
Hsueh-Yuan Chang, Shengjia Wu, Guy Meno-Tetang, Dhaval K Shah
A translational platform PBPK model for antibody disposition in the brain. Journal of pharmacokinetics and pharmacodynamics 46 (4) (2019)
Hsueh-Yuan Chang, Kasey Morrow, Emily Bonacquisti, WanYing Zhang, Dhaval K Shah
Antibody pharmacokinetics in rat brain determined using microdialysis. mAbs 10 (6) (2018)

Dhaval K Shah.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dhaval K Shah